$2.5 M Risperdal Verdict Upheld in Superior Court
The Pennsylvania Superior Court has upheld the 2015 $2.5 million Risperdal verdict for plaintiff Austin Pledger. Pledger’s case was the first Risperdal case to go to trial. Viewed as a huge win for plaintiffs, the decision bodes well for the future litigation of 6,500 plaintiffs whose suits against Janssen Pharmaceutical, a subsidiary of Johnson & […]
HHS Pick, Former Eli Lilly Exec, Grilled over Zyprexa Scandal
Sheller’s New Book Available, Read the First Chapter
NOW AVAILABLE ONLINE AND BY REQUEST AT YOUR LOCAL BOOKSTORE — Click here to buy the book online — PHARMAGEDDON: A Nation Betrayed A National Trial Lawyer Reveals an Industry Spinning Out of Control by Stephen A. Sheller, Esq. with New York Times best-selling author Sidney D. Kirkpatrick […]
In The New York Times: “Side Effects May Include Lawsuits”
One of the most-read articles in The New York Times regarding pharmaceutical drug product liability and whistleblower lawsuits quotes Stephen Sheller. Side Effects May Include Lawsuits BY DUFF WILSON NEW YORK – FOR decades, antipsychotic drugs were a niche product. Today, they’re the top-selling class of pharmaceuticals in America, generating annual revenue of about $14.6 billion […]
